2,041 results on '"McCluggage, W Glenn"'
Search Results
52. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type
53. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii
54. Teratoma‐associated and so‐called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features
55. Macroscopic examination of pathology specimens: a critical reappraisal
56. Pan‐TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls
57. FIGO 2023 endometrial cancer staging: too much, too soon?
58. Correlation of PD-L1 expression with immunohistochemically determined molecular profile in endometrial carcinomas
59. Reply to Letter by Cyrta et al, Entitled "Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)".
60. DICER1-associated sarcomas: towards a unified nomenclature
61. Cervical Small Cell Variant of Paraganglioma With Sarcomatous Transformation: Report of a Unique Case
62. Defining the molecular evolution of extrauterine high grade serous carcinoma
63. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma
64. A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas
65. FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer
66. Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
67. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum
68. Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series
69. Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma
70. An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
71. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions
72. Pelvic and Ovarian Recurrence of Small HPV-associated Cervical Adenocarcinoma With Transformation to Neuroendocrine Carcinoma
73. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinoma and Tumor-associated Immune Cells: Differences Between MLH1 Methylated and Nonmethylated Subgroups
74. DICER1-sarcoma: an emerging entity
75. Teratoma‐associated and so‐called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features.
76. Macroscopic examination of pathology specimens: a critical reappraisal.
77. “Deciduoid” Change in Uterine Leiomyomas in Pregnancy: Aberrant Expression of Sex Cord Markers Inhibin and Calretinin.
78. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
79. Pan‐TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
80. Cervical Adenoid Basal Carcinoma With High-grade Squamous Component: True Mixed Carcinoma or Colonization of Adenoid Basal Carcinoma by High-grade Squamous Intraepithelial Lesion?
81. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
82. SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors
83. Immunohistochemistry and Molecular Diagnostics in the Differential Diagnosis of Female Genital Tract Pathology
84. List of Contributors
85. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma
86. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study
87. Mesenchymal and Mixed Epithelial-Mesenchymal Neoplasms of the Cervix
88. Fallopian Tube
89. Cervix
90. Vulva
91. Uterus
92. Ovary
93. Personalized histopathology reporting for personalized medicine: a plea for improved communication
94. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer
95. Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging
96. The developing spectrum of gastric-type cervical glandular lesions
97. Vulvovaginal mesenchymal lesions: a review and update
98. The Value of DICER1 Mutation Analysis in “Subtle” Diagnostically Challenging Embryonal Rhabdomyosarcomas of the Uterine Cervix
99. Skene’s Gland Derivatives in the Female Genital Tract and Cervical Adenoid Basal Carcinoma are Consistently Positive With Prostatic Marker NKX3.1
100. Uterine Adenosarcoma Originating in Adenomyosis: Report of an Extremely Rare Phenomenon and Review of Published Literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.